Except for lung cancers [6], endometrial cancers [7] and leiomyomas [8], the level of cyr61 expression has been found to be increased in various human cancers including breast, rhabdomyosarcomas, melanomas, gliomas, gastric, colon, bladder papillomas and prostate cancers[9-13]. The gene discussed is CCN1; the disease is cancer.